Nishioka, Hiroaki <br/><br/>
Disseminated cryptococcosis in a patient taking tocilizumab for Castleman's disease.  [electronic resource] 

 -  Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy  Feb 2018 
 - 138-141 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1437-7780 
<br/><br/><label>Standard No.: </label>10.1016/j.jiac.2017.09.009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amphotericin B--therapeutic use<br/>Anti-Inflammatory Agents--therapeutic use<br/>Antibodies, Monoclonal, Humanized--adverse effects<br/>Antifungal Agents--therapeutic use<br/>Castleman Disease--drug therapy<br/>Cryptococcosis--diagnosis<br/>Cryptococcus neoformans--isolation & purification<br/>Cyclosporine--therapeutic use<br/>Fluconazole--therapeutic use<br/>Humans<br/>Immunosuppressive Agents--adverse effects<br/>Male<br/>Middle Aged<br/>Prednisolone--therapeutic use<br/>Risk Factors